A Novel Polymorphic AP-1 Binding Element of the GFAP Promoter is Associated with Different Allelic Transcriptional Activities

Annals of Human Genetics

Volumn 74, Issue 6, 2010, Pages 506-515

  Bachetti, Tiziana ^a   DiZanni, Eleonora ^a   Lantieri, Francesca ^a,b   Caroli, Francesco ^a   Regis, Stefano ^a   Filocamo, Mirella ^a   Rainero, Innocenzo ^c   Gallone, Salvatore ^c   Cilia, Roberto ^d   Romano, Silvia ^e   Savoiardo, Mario ^f   Pareyson, Davide ^f   Biancheri, Roberta ^a   Ravazzolo, Roberto ^a,b   Ceccherini, Isabella ^a  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d Istituti Clinici di Perfezionamento   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

AP 1; GFAP promoter; Single nucleotide polymorphisms

Indexed keywords

CYTOKINE; CYTOSKELETON PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GROWTH FACTOR; HORMONE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

ARTICLE; ASTROCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA POLYMORPHISM; GENE LINKAGE DISEQUILIBRIUM; GLIOSIS; HAPLOTYPE; HUMAN; INTERMEDIATE FILAMENT; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION;

ALLELES; ASTROCYTES; BINDING SITES; CELL LINE; GENE FREQUENCY; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; ITALY; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 77958180258     PISSN: 00034800     EISSN: 14691809     Source Type: Journal    
DOI: 10.1111/j.1469-1809.2010.00614.x     Document Type: Article

References (34)

1. Bachetti, T., Caroli, F., Bocca, P., Prigione I., Balbi, P., Biancheri, R., Filocamo, M., Mariotti, C., Pareyson, D., Ravazzolo, R. & Ceccherini, I. (2008) Mild functional effects of a novel GFAP mutant allele identified in a familial case of adult-onset alexander disease. Eur J Hum Genet 16, 462-470.
2. Bae, M. K., Kim, S. R., Lee, H. J., Wee, H. J., Yoo, M. A., Ock, O. S., Baek, S. Y., Kim, B. S., Kim, J. B., Sik-Yoon & Bae, S. K. (2006) Aspirin-induced blockade of NF-κB activity restrains up-regulation of glial fibrillary acidic protein in human astroglial cells. Biochim Biophys Acta, 1763, 282-289.
3. Barret, J. C., Fry, B., Maller, J. & Daly, M. J. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263-265.
4. Brenner, M. (1994) Structure and transcriptional regulation of the GFAP gene. Brain Pathol 4, 245-257.
5. Brenner, M., Johnson, A. B., Boespflug-Tanguy, O., Rodriguez, D., Goldman, J. & Messing, A. (2001) Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet, 27, 117-120.
6. Brenner, M., Kissebert, W. C., Su, Y., Besnard, F. & Messing, A. (1994) GFAP promoter directs astrocytes-specific expression in transgenic mice. J Neurosci, 14, 1030-1037.
7. Chiu, R., Boyle, W. J., Meek., Smeal, T., Hunter, T. & Karin, M. (1988) The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell, 54, 541-552.
8. Cho, W., Hagemann, T. L., Johnson, D. A., Johnson, J. A. & Messing, A. (2009) Dual transgenic reporter mice as a toll for monitoring expression of glial fibrillary acidic protein. J Neurochem, 110, 343-351.
9. De Leeuw, B., Su, M., Ter Horst, M., Iwata, S., Rodijk, M., Hoeben, R. C., Messing, A., Smitt, P. S. & Brenner, M. (2006) Increased glia-specific transgene expression with glial fibrillary acidic protein promoters containing multiple enhancer elements. J Neurosci Res, 83, 744-753.
10. Eliasson, C., Sahlgren, C., Berthold, C-H., Stakenberg, J., Celis, J. E., Betsholtz, C., Eriksson, J. E. & Pekny, M. (1999) Intermediate filaments protein partnership in astrocytes. J Biol Chem, 34, 23996-24006.
11. Farré, D., Roset, R., Huerta, M., Adsuara, J. E., Roselló, L., Mar Albà, M. & Messeguer, X. (2003) Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res, 31, 3651-3653.
12. Gomes, F. C. A., Paulin, D. & Moura Neto, V. (1999) Glial acidic fibrillary protein (GFAP): modulation by growth factors and its implication in astrocytes differentiation. Braz J Med Biol Res, 32, 619-631.
13. 1-antichymotrypsin and glial fibrillary acidic protein genes requires activator protein-1. J Biol Chem, 281, 1956-1963.
14. Juhyung, L., Chi-Hoon, P., Wook-Hwan, K., Yung Ha, H., Kyungchae, J. & Chul-Hak, Y. (2006) Inhibitory effects of Momordin I derivatives on the formation of Fos-Jun-AP-1 DNA complex. Bull Korean Chem Soc, 27, 535-538.
15. Kahn, M. A., Huang, C. J., Caruso, A., Barresi, V., Nazarian, R., Condorelli, D. F. & De Vellis J. (1997) Ciliary neurotrophic factor activates JAK/Stat signal transduction cascade abd induces transcriptional expression of glial fibrillary acidic protein in glial cells. J Neurochem, 68, 1413-1423.
16. Koyama, Y. & Goldman, J. (1999) Formation of GFAP cytoplasmic inclusions in astrocytes and their disaggregation by, αB-crystallin. Am J Pathol, 154, 1563-1572.
17. Laping, N. J., Teter, B., Nichols, N. R., Rozovsky, I. & Finch, C. E. (1994) Glial fibrilary acidic protein: regulation by hormones, cytokines and growth factors. Brain Pathol, 4, 259-275.
18. Lee, Y., Messing, A., Su, M. & Brenner, M. (2008) GFAP promoter elements required for region-specific and astrocyte-specific expression. Glia, 56, 481-493.
19. Masood, K., Besnard, F. & Brenner, M. (1993) Analysis of a segment of the human glial fibrillary acidic protein gene that direct astrocyte-specific transcription. J Neurochem, 61, 160-166.
20. Menet, V., Giménez, Y., Ribotta, M., Chauvet, N., Drian, M. J., Lannoy, J., Colucci-Guyon, E. & Privat, A. (2001) Inactivation of the glial fibrillary acidic protein gene, but not that of vimentin, improves neuronal survival and neurite growth by modifying adhesion molecule expression. J Neurosci, 21, 6147-6158.
21. Messeguer, X., Escudero, R., Farré, D, Nuñez, O., Martínez, J. & Mar Albà, M. (2002) PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics, 18, 2, 333-334.
22. Messing, A, Head, M. W., Galles, K., Galbreath, E. J., Goldman, J. E. & Brenner, M. (1998) Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice. Am J Pathol, 152, 391-398.
23. Myers, A. J., Gibbs, J. R., Webster, J. A., Rohrer, K., Zhao, A., Marlowe, L., Kaleem, M., Leung, D., Bryden, L., Nath, P., Zismann, V. L., Joshipura, K., Huentelman, M. J., Hu-Lince, D., Coon, K. D., Craig, D. W., Pearson, J. V., Holmans, P., Heward, C. B., Reiman, E. M., Stephan, D. & Hardy, J. (2007) A survey of genetic human cortical gene expression. Nat Genet, 39, 1494-1499.
24. Okun, E., Griffioen, K. J., Lathia, J. D., Tang, S. C., Mattson, M. P. & Arumugam, T. V. (2009) Toll-like receptors in neurodegeneration. Brain Res Rev, 59, 278-292.
25. Pekny, M., Levéen, P., Pekna, M., Eliasson, C., Berthold, C. H., Westermark, B. & Betsholtz, C. (1995) Mice lacking glial fibrillary acidic protein display astrocytes devoid of intermediate filaments but develop and reproduce normally. EMBO J, 14, 1590-1598.
26. Perng, M. D., Su, M., Wen, S. F, Gibbon, T., Prescott, A. R., Brenner, M. & Quinlan, R. A. (2006) The Alexander disease-causing Glial Fibrillary Acidic Protein mutant, R416W, accumulates into Rosenthal fibers by a pathway that involves filament aggregation and the association of, αB-Crystallin and HSP27. Am J Hum Genet, 79, 197-213.
27. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A., Bender, D., Maller, J., Sklar, P., De Bakker, P. I., Daly, M. J. & Sham, P. C. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet, 81, 559-575.
28. Quinlan, R. A., Brenner, M., Goldman, J. E. & Messing, A. (2007) GFAP and its role in Alexander disease. Exp Cell Res, 313, 2077-2087.
29. Raucher, F. J., III, Voulalas, P. J., Franza, B. R., Jr & Curran, T. (1988) Fos and Jun bind cooperatively to the AP-1 site: reconstitution in vitro. Genes Develop, 2, 1687-1699.
30. Schreiber, E., Matthias, P., Müller, M. M. & Schaffner, W. (1989) Rapid detection of octamer binding proteins with 'mini extracts', prepared from a small number of cells. Nucleic Acids Res, 17, 6419.
31. Stephens, M., Smith, N. & Donnelly, P. (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet, 68, 978-989.
32. Su, M., Hu, H., Lee, Y., D'Azzo, A., Messing, A. & Brenner, M. (2004) Expression specificity of GFAP transgenes. Neurochem Res, 29, 2075-2093.
33. Tanaka, R., Takebayashi, H., Yamakazi, Y., Ono, K., Naruse, M., Iwasato, T., Itohara, S., Kato, H. & Ikenaka, K. (2007) Murine model of Alexander disease: analysis of GFAP aggregate formation and its pathological significance. Glia, 55, 617-631.
34. Tang, G., Perng, M. D., Wilk, S., Quinlan, R. & Goldman, J. E. (2010) Oligomers of mutant glial fibrillary acidic protein (GFAP) Inhibit the proteasome system in alexander disease astrocytes, and the small heat shock protein alphaB-crystallin reverses the inhibition. J Biol Chem, 285, 10527-10537.